we our call. third to Officer. Thank by followed by on quarter on am and level our our Brent of third welcome discussion you, with update a of line will I operator our factors results quarter everyone third the financial today that Financial quarter an drove earnings areas high the remarks I financial performance, and Moen, and the then session. begin operational Chief release. will our updated have a joined review and And earnings recent Brent the press XXXX our for finally, today review in before of results we XXXX in financial guidance, our continued will on some progress our some focus begin thoughts updated made. outlook provide which quarterly of greater I we our cover detail Q&A
anticipated year-over-year. products to came revenue of results earnings airway million the These year-over-year, third for to XX So, let’s growth third well get reported on XX% quarter QX started Sales with call. expectation of our a for revenue, were year-over-year. we review growth $XX.X percentage of approximately We largest clearance total total discussed points quarter, the of our above financial revenue XX% to growth contributing performance. our of contributor which stronger our representing in than XX% our our
modestly year-over-year, growth We are increase lymphedema had range we anticipated. see X% which pleased revenue to X% our the exceeded X% from products also to
improvements maintaining while year-over-year compared increasing gross, delivered balance. strong year, performance, cash our EBITDA our solid sales to in addition operating also our and our we significant prior In margins the adjusted profitability, to
products primary a challenges our clearance Turning the At At a business several second remain. company of of modest compared of improvement quarter level, factors. lymphedema related the pockets a our staffing launch do initiatives patient saw feature sales level, has clinics to combination of we benefited – volumes a from new clinics that and to lymphedema innovation engagement reps of launch first our discussion the a as nice the clinic half they targeted lymphedema from as our high level contributed two services. performance referral and we airway in drivers following in our with saw to in although new of the to In a reengage reps ComfortEase July. for they work to particular, our training year been and garment the our walk sales of
by Additionally, of lastly emerging our we improving were clinician also are engagement. at of team, fully the a the level, sales pleased and retention consequence pleased quarter both space message. the garments to added ComfortEase products. from in where the notable new saw and we fresh customers lymphedema channel vascular following response in our the launch existing third stabilization exiting in And staffed, we a the most was field see This new
generating in million our we the airway AffloVest, another clearance slightly In $XX enjoyed over revenue. strong products, of namely very quarter lymphedema addition the impressive products, to our sales with
a the performance both in respiratory reflects in DME last of growth assuming on standalone about airway clearance the adoption quarter acquired its basis, we only reminder, clearance third X line of AffloVest XXX% As of year-over-year weeks in the of remained booked separate the our XXXX. This and quarter partnered however, of among a year September with. sales product we product a business airway third and entity reps X had the XXXX. it periods, the system On have achieved ongoing
favorable strong these As well by pulmonary and a to serve, partners. With patients these at-home I from to via left likely demand as product it with infections DME’s patients for of leading case patients from previously, compelling qualified is with both therapy to existing the have clearance clinicians are within driven require are existing existing the and described The our compelling portfolios them as referral standpoint, to that hospitalization, clearance is economic for coupled at-home respiratory and new complementary benefit seeing customer are receives AffloVest. base recurring networks. AffloVest channel this eligible we if airway a we that pneumonias. partners eligible therapy they one products, are treatment identifying largely believe due untreated, And need the airway reimbursement, an AffloVest DME making our backdrop, that a
been we patients, benefiting untreated, left unidentified reveal to treat pleased reps. of that both or would is chronic those in couldn’t otherwise therapy also efforts growth which homes. in the for if be Importantly, We with and be patients more our to underserved diseases believe from countless mission not to their have keeping underserved suffering these AffloVest from is bringing identifying Tactile’s
demand see team to by to During networks, aided represents This to DMEs expand AffloVest our relief the one respiratory and important we in bringing branches availability significant as branches to of runway continue driver third existing of quarter, their another of the patients. additional also more number DME our of AffloVest’s and specialists. expand reps, was the within part in continued partners we
expanding capacity. to Lastly, make production in from AffloVest our side, supply continue a we progress
We also progress inventory And to although demand, initial new our are support able our from continue remains we their supplier. second some closely secure spot on initial supplier existing buys. to to dependent with work
acquisitions track we supplier the running initial rest forward. end, leverage expect ago, some expect second largest up It phases to demand strong generated year we the our of period clearance Stepping revenue under to-date. had we channel. should of in we on remained to validating back, the over XX-month year business be While within million us lumpiness prior pace fully our keep strategy with going remain acquired the the and its to just the position and $XX Tactile through with in by airway it the DME represented which year, when a
the we Given that are July, the achieved convinced quarter important our release market lymphedema two have Kylee our and right notably right by solutions note in in pursuing year, highlights, improving began garments, clearance and we upwards we application. It’s product from the our last and third focus Medical now on generate latest of to development. strategy focus patients, operational to these profitability. product review this ComfortEase enhance revenue introductions R&D year the progress we full X delivering that asset sustainable of with on over new the are mobile to first our support guidance, represent Shifting airway to we over the fact our and most years growth our as updated and $XX million Tactile indicated expect to effort in new of reflect our multiyear the our for our
with recent on of me respect solutions. these Let each you to progress our update
extremities. ComfortEase our our with designed garments reminder, lower system a used the on Flexitouch As to be are
intended while goal the to by user more more have in off, it and patient These was of on goal to with cooler lighter, mind, primary to malleable to improve and patients, and comfort. our easier overall patients for lower within generation experience and insisting of on of management like issues and proven to Flexitouch in results. make mobility, enhance promote ComfortEase ease preserving be adherence our ComfortEase were were lymphedema them out designing With are extremities use, designed limited our article clinically daily garments Our also were this facilitate to so of patient intuitive Many at ultimately and our garments their this patients treatment fit, any these help improving created materials put the strong home. of in much delivering optimal train to other outcomes. their clothing overcome developed garments improvements take lymphedema latest comfort
sales trainers, release, excellent and the full importantly, received from patients. clinicians, most our our reps, have market Following feedback we
Our with of we a and mentioned patient our as garments to new broadly more prescribers. excited that to level use. existing I are have and customer reps potential intuitive engagement And they easier pleased earlier, trainers with have patients our are product new facilitate shared seeing. are ComfortEase are the clinician to conversations And finding
Importantly, they and more patients seeing on to with that are limited are put mobility garments take ComfortEase able off easily.
mobile iOS a Kylee our effective pleased the launch our been platforms. the and is definitive lymphedema This both received earlier to towards treatment. expand in and also app their application of have are We that journey patients support for following feedback for intended the obtaining diagnosis with Android
and the among one practitioners Flexitouch eligibility office use more and along for shortening given doing journey. shown of entree our has among will even progression. diagnosis three takes better easily the to arrive or lymphedema, app they and specialty that disease a effectively we to of their onset an to Kylee to With little then be available able it easily treatment about which awareness is receives following complete time Kylee, engagement entree ultimately and to and lymphedema analysis the comes patients average obtain doctor’s lymphatic the options understanding of a on medical an the so, unsurprising and Plus patient symptoms the when it training, believe document exists In receives attention tutorial can takes systems. source their FAQ it at their most underscores informed, years a support. use that definitive system product videos obtain in of the or Flexitouch, as the more app to or it lymphedema is healthcare also can their X Once patient healthcare use they or training our programs. lack providers learn the of average with This Our
our introducing app available patients prescribers Following its doctor’s their and in-clinic making social the media on we focused to via to through clinician demos it our platforms. offices, in and launch, patient Kylee
patients to with scores is including we more reducing video scores in of an equally cost for device, early, satisfaction finding ways continue grow satisfaction and While is also their In in-home to training overall the experience. to understand documents while to delivering responding expected Kylee and Key our efficiently, us easy engagement. still high some patient to time, orders immediately in its initiating process serve. upon with to but therapy receipt those ongoing our seen high have utility, vignettes patient a path exchange to as
of X,XXX continuing of hosted educational In programs XX Year-to-date, U.S. nearly clinician X,XXX approximately events. by stronger we were lymphedema. focused programs educational participants, to plan quarter, and attended continue over our including in-person We addition we educational to third All-in-all, survivorship and In hosting proper medical excited and clinician education than use Brent? for updated of complement a trained financial virtually. our effective were the XXX review the within awareness we lymphedema in-person participants. community both performance its continued events financial lymphedema, cancer-related results on the app, progress hosted expected cancer-related our treatment total with in promoting that and quarter. we along are through the more our virtual with Kylee to now Brent mobile detail, financial third raise management and quarter will operational third during to have guidance.
